SORBENT REMOVAL OF ANTI-CANCER DRUGS

被引：0
|
作者：
RAHMAN, A
WINCHESTER, JF
KESSLER, A
SLAVIK, M
SCHEIN, P
机构：
[1] GEORGE WASHINGTON UNIV,SCH MED,VINCENT T LOMBARDI CANC RES CTR,DIV MED ONCOL,WASHINGTON,DC 20007
[2] GEORGE WASHINGTON UNIV,SCH MED,DIV NEPHROL,WASHINGTON,DC 20007
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1978年 / 19卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [21] EFFECT OF ANTI-CANCER DRUGS ON COMPLEMENT
    MCKENZIE, D
    CLOSKY, J
    HETRICK, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1970, 11 : 54 - &
  • [22] FORMULATION OF INVESTIGATIONAL ANTI-CANCER DRUGS
    REPTA, AJ
    PHARMACY INTERNATIONAL, 1981, 2 (07): : ABS2 - ABS2
  • [23] THE RISING COST OF ANTI-CANCER DRUGS
    Karikios, D. J.
    Schofield, D.
    Salkeld, G.
    Mann, K. P.
    Trotman, J.
    Stockler, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E35 - E35
  • [24] Anthelmintics as Potential Anti-Cancer Drugs?
    Heo, Dae Seog
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (06)
  • [25] Anti-Cancer Drugs: The mitochondrial paradox
    Penman, Sophie L.
    Jensen, Rebecca L.
    Kiy, Robyn T.
    Chadwick, Amy E.
    ELIFE, 2020, 9
  • [26] Is the Price of Anti-Cancer Drugs Justified?
    Guillot, B.
    ONCOLOGIE, 2017, 19 (11-12) : 381 - 385
  • [27] Are isothiocyanates potential anti-cancer drugs?
    Xiang Wu
    Qing-hua Zhou
    Ke Xu
    Acta Pharmacologica Sinica, 2009, 30 : 501 - 512
  • [28] APPROACHES TO EFFECTIVE ANTI-CANCER DRUGS
    NEIDLE, S
    NATURE, 1977, 268 (5617) : 195 - 196
  • [29] Developing New Anti-Cancer Drugs
    Pereira, Ricardo de Souza
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (01) : 1 - 5
  • [30] Intrinsically Fluorescent Anti-Cancer Drugs
    Kabir, Md Lutful
    Wang, Feng
    Clayton, Andrew H. A.
    BIOLOGY-BASEL, 2022, 11 (08):
12345